I V Machado - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

I V Machado

Showing results (11-20 of 17) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 17 results.

Viral Immunology|January 1, 1994

CD3- and CD28-activating pathways in HCV infectionJ A Corado, F I Toro, M L Baroja, et al.

Viral Immunology|January 1, 1996

T cell hyperreactivity to IL-6 in chronic nonviremic HBV carriers despite normal IL-6 receptor or gp130 expressionM L Baroja, F L Sirit, H Rivera, et al.

Journal of Medical Virology|December 1, 1992

Assessment of former and newly developed HBV assays in a Third World settingM E Zabaleta, F I Toro, M E Ruiz, et al.

Kidney International|April 1, 1992

Risk factors for dialysis-associated hepatitis C in VenezuelaG Y Muller, M E Zabaleta, A Arminio, et al.

Progress in Clinical and Biological Research|January 1, 1991

Assessment of delta virus infection in Venezuelan high-risk population for hepatitis B virusI V Machado, L Deibis, M Zabaleta, et al.

Clinical Immunology and Immunopathology|November 1, 1993

Anti-CD3-activated T cells from chronic nonviremic HBV carriers are hyperreactive to monocytic accessory signalsM L Baroja, F L Sirit, D J Caldera, et al.

G.E.N|July 1, 1994

[Immunoclinical, molecular and immunopathologic approach to chronic viral hepatitis. Therapeutic considerations]I V Machado, L Deibis, E Risquez, et al.

Pageof 2

Search research articles

Showing results (11-20 of 17) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 17 results.

Viral Immunology|January 1, 1994

CD3- and CD28-activating pathways in HCV infectionJ A Corado, F I Toro, M L Baroja, et al.

Viral Immunology|January 1, 1996

T cell hyperreactivity to IL-6 in chronic nonviremic HBV carriers despite normal IL-6 receptor or gp130 expressionM L Baroja, F L Sirit, H Rivera, et al.

Journal of Medical Virology|December 1, 1992

Assessment of former and newly developed HBV assays in a Third World settingM E Zabaleta, F I Toro, M E Ruiz, et al.

Kidney International|April 1, 1992

Risk factors for dialysis-associated hepatitis C in VenezuelaG Y Muller, M E Zabaleta, A Arminio, et al.

Progress in Clinical and Biological Research|January 1, 1991

Assessment of delta virus infection in Venezuelan high-risk population for hepatitis B virusI V Machado, L Deibis, M Zabaleta, et al.

Clinical Immunology and Immunopathology|November 1, 1993

Anti-CD3-activated T cells from chronic nonviremic HBV carriers are hyperreactive to monocytic accessory signalsM L Baroja, F L Sirit, D J Caldera, et al.

G.E.N|July 1, 1994

[Immunoclinical, molecular and immunopathologic approach to chronic viral hepatitis. Therapeutic considerations]I V Machado, L Deibis, E Risquez, et al.

Pageof 2